Kymanox® Announces Facility Expansion to Enhance CGxP Space and Laboratory Service Offerings King of Prussia, Pennsylvania USA, June 03, 2024 (GLOBE NEWSWIRE) -- Kymanox is pleased to announce the expansion of its device design and testing facility in King of Prussia (KOP), PA, which will...

New AAMI Guidance on Combination Products and FDA CGMPs Arlington, Virginia, May 30, 2024 (GLOBE NEWSWIRE) -- As the breadth and scope of combination products around the world continues to ramp up, are U.S. manufacturers equipped with the best design...

NEUMA, The Design And Testing Arm Of Kymanox, Moves To New Headquarters Morrisville, North Carolina USA and King of Prussia, Pennsylvania USA, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Kymanox Corporation (“Kymanox”), a professional services company exclusively serving the life...

Lubrizol übernimmt die Bavaria Medizin Technologie GmbH CLEVELAND, July 15, 2019 (GLOBE NEWSWIRE) -- Die Lubrizol Corporation gibt die Übernahme der Bavaria Medizin Technologie GmbH (BMT), eines innovativen Entwicklers und Herstellers von intravaskulären...

Lubrizol Acquires Bavaria Medizin Technologie GmbH CLEVELAND, July 15, 2019 (GLOBE NEWSWIRE) -- The Lubrizol Corporation announces the acquisition of Bavaria Medizin Technologie GmbH (BMT), an innovative designer and manufacturer of both...